UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Effect of Internet-Delivered Cognitive Behavioral Therapy Versus Psychoeducation Only on Psychological Distress in Patients With Noncardiac Chest Pain: Randomized Controlled Trial

Journal of medical Internet research, 2022-01, Vol.24 (1), p.e31674-e31674

2022

Volltextzugriff (PDF)

Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013–2020

Clinical research in cardiology, 2024-09, Vol.113 (9), p.1355-1368

2024

Volltextzugriff (PDF)

Resting Full-Cycle Ratio versus Fractional Flow Reserve: A SWEDEHEART-Registry-Based Comparison of Two Physiological Indexes for Assessing Coronary Stenosis Severity

Journal of interventional cardiology, 2023-06, Vol.2023, p.6461691-9

2023

Volltextzugriff (PDF)

Effects of brief mindfulness-based cognitive behavioural therapy on health-related quality of life and sense of coherence in atrial fibrillation patients

European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 2018-10, Vol.17 (7), p.589-597

2018

Volltextzugriff (PDF)

Sodium‐glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure

ESC Heart Failure, 2024-02, Vol.11 (1), p.327-337

2024

Volltextzugriff (PDF)

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome

European journal of heart failure, 2011-10, Vol.13 (10), p.1096-1103

2011

Volltextzugriff (PDF)

Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study

Frontiers in oncology, 2023, Vol.13, p.1095251-1095251

2023

Volltextzugriff (PDF)

Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies

International journal of cardiology, 2024-10, Vol.412, p.132304, Article 132304

2024

Volltextzugriff (PDF)

Heart failure registries – Future directions

Journal of cardiology, 2024-02, Vol.83 (2), p.84-90

2024

Volltextzugriff (PDF)

Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry

European journal of heart failure, 2022-11, Vol.24 (11), p.2093-2104

2022

Volltextzugriff (PDF)

The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study

International journal of cardiology, 2017-06, Vol.236, p.315-320

2017

Volltextzugriff (PDF)

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data

Systematic reviews, 2018-07, Vol.7 (1), p.112-21, Article 112

2018

Volltextzugriff (PDF)

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials

European journal of heart failure, 2015-12, Vol.17 (12), p.1252-1261

2015

Volltextzugriff (PDF)

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI

European heart journal. Cardiovascular pharmacotherapy, 2024-09

2024

Volltextzugriff (PDF)

Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study

BMC cardiovascular disorders, 2016-02, Vol.16 (39), p.39-39, Article 39

2016

Volltextzugriff (PDF)

Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

European heart journal. Cardiovascular pharmacotherapy, 2023-06, Vol.9 (4), p.343-352

2023

Volltextzugriff (PDF)

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

European heart journal. Cardiovascular pharmacotherapy, 2023-03, Vol.9 (2), p.192-197

2023

Volltextzugriff (PDF)

Responder to BNP-guided treatment in heart failure. The process of defining a responder: Results from the Use of PeptideS in Tailoring hEart failure Project or UPSTEP study

Scandinavian cardiovascular journal : SCJ, 2015-11, Vol.49 (6), p.316-324

2015

Volltextzugriff (PDF)

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

European heart journal, 2014-06, Vol.35 (23), p.1559-1567

2014

Volltextzugriff (PDF)

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

European journal of heart failure, 2024-09

2024

Volltextzugriff (PDF)

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

The New England journal of medicine, 2024-04, Vol.390 (15), p.1372-1381

2024

Volltextzugriff (PDF)

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

European heart journal. Acute cardiovascular care, 2024-10

2024

Volltextzugriff (PDF)

Heart Failure – Biomarker Effect and Influence on Quality of Life

Karlström, Patric

2016

Volltextzugriff (PDF)

Corrigendum to 'Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome' [Eur J Heart Fail 2011;13:1096-1103]

European journal of heart failure, 2012-05, Vol.14 (5), p.563-563

2012

Volltextzugriff (PDF)

Responder to BNP-guided treatment in heart failure. The process of defining a responder

Scandinavian cardiovascular journal : SCJ, 2015, Vol.49 (6), p.316-324

2015

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(24)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)
Dissertationen
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

The Effect of Internet-Delivered Cognitive Behavioral Therapy Versus Psychoeducation Only on Psychological Distress in Patients With Noncardiac Chest Pain: Randomized Controlled Trial

Modern heart failure treatment is superior to conventional treatment across the left ventricular ejection spectrum: real-life data from the Swedish Heart Failure Registry 2013–2020

Resting Full-Cycle Ratio versus Fractional Flow Reserve: A SWEDEHEART-Registry-Based Comparison of Two Physiological Indexes for Assessing Coronary Stenosis Severity

Effects of brief mindfulness-based cognitive behavioural therapy on health-related quality of life and sense of coherence in atrial fibrillation patients

Sodium‐glucose cotransporter 2 inhibitors are associated with reduced risk of mortality and readmissions in heart failure

Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome

Long-term and real-life incidence of cancer therapy-related cardiovascular toxicity in patients with breast cancer: a Swedish cohort study

Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies

Heart failure registries – Future directions

Trajectories in New York Heart Association functional class in heart failure across the ejection fraction spectrum: data from the Swedish Heart Failure Registry

The impact of time to heart failure diagnosis on outcomes in patients tailored for heart failure treatment by use of natriuretic peptides. Results from the UPSTEP study

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data

Which heart failure patients profit from natriuretic peptide guided therapy? A meta-analysis from individual patient data of randomized trials

Effects of beta-blockers on quality of life and well-being in patients with myocardial infarction and preserved left ventricular function-a prespecified substudy from REDUCE-AMI

Can BNP-guided therapy improve health-related quality of life, and do responders to BNP-guided heart failure treatment have improved health-related quality of life? Results from the UPSTEP study

Eligibility for sotagliflozin in a real-world heart failure population based on the SOLOIST-WHF trial enrolment criteria: data from the Swedish heart failure registry

Design and rationale of randomized evaluation of decreased usage of beta-blockers after acute myocardial infarction (REDUCE-AMI)

Responder to BNP-guided treatment in heart failure. The process of defining a responder: Results from the Use of PeptideS in Tailoring hEart failure Project or UPSTEP study

Effect of B-type natriuretic peptide-guided treatment of chronic heart failure on total mortality and hospitalization: an individual patient meta-analysis

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Beta-Blockers after Myocardial Infarction and Preserved Ejection Fraction

Short- and long-term effects of beta-blockers on symptoms of anxiety and depression in patients with myocardial infarction and preserved left ventricular function: a pre-specified quality of life sub-study from the REDUCE-AMI trial

Heart Failure – Biomarker Effect and Influence on Quality of Life

Corrigendum to 'Brain natriuretic peptide-guided treatment does not improve morbidity and mortality in extensively treated patients with chronic heart failure: responders to treatment have a significantly better outcome' [Eur J Heart Fail 2011;13:1096-1103]

Responder to BNP-guided treatment in heart failure. The process of defining a responder

Suchergebnisse filtern